170 related articles for article (PubMed ID: 303541)
1. Cell-mediated immune status of colon cancer patients: evaluation by dermal antigen testing, measurment of lymphocyte stimulation and counts of peripheral blood rosette-forming cells.
Evans JT; Goldrosen MH; Minowada J; Howell J; Mittelman A; Chu TM; Holyoke ED
Cancer; 1977 Nov; 40(5 Suppl):2716-25. PubMed ID: 303541
[No Abstract] [Full Text] [Related]
2. Lymphocyte subpopulations in colo-rectal cancer. Preoperative evaluation.
Hernández JL; Sanz ML; Crisci CD; Voltas J; Subirá ML; Zornoza G; Oehling A
Allergol Immunopathol (Madr); 1978; 6(4):339-44. PubMed ID: 310638
[TBL] [Abstract][Full Text] [Related]
3. Immunologic studies of colonic cancer: evaluation of immunocompetence.
Ichiki AT; Collmann IR; Wenzel KL; Sonoda T; Krauss S
South Med J; 1978 Mar; 71(3):271-6. PubMed ID: 305116
[TBL] [Abstract][Full Text] [Related]
4. Peripheral lymphocytes in carcinoma of the colon and rectum.
Slater GI; Kim US; Papatestas AE; Aufses AH
Surg Gynecol Obstet; 1979 Nov; 149(5):719-21. PubMed ID: 505246
[TBL] [Abstract][Full Text] [Related]
5. Lack of correlation of T and B lymphocytes with stage of colorectal carcinoma.
Neilan BA
Dis Colon Rectum; 1980 Mar; 23(2):65-7. PubMed ID: 6966563
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of lymphocyte-mediated cytotoxicity after tumor resection in patients with colorectal cancer.
Waller CA; Gill PG; MacLennan IC
J Natl Cancer Inst; 1980 Aug; 65(2):223-30. PubMed ID: 6931244
[TBL] [Abstract][Full Text] [Related]
7. [Determination of the lymphocytic and oncofetal antigen subpopulations in patients with adenocarcinomas of the stomach and of the colon and rectum (author's transl)].
Voltas J; Sanz ML; Hernández JL; Crisci CD; Subirá ML; Zornoza G
Med Clin (Barc); 1979 Dec; 73(10):419-23. PubMed ID: 93670
[TBL] [Abstract][Full Text] [Related]
8. [Immunologic profile of patients with carcinoma of the colorectum in the aged].
Melita P; Gorgone S; Labruto G; Belnome NA; Palmeri R; Liotta G
Chir Ital; 1983 Oct; 35(5):623-33. PubMed ID: 6084562
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of peripheral lymphocyte counts and association with CEA in colorectal cancer.
Kim U; Papatestas AE; Aufses AH
Surg Forum; 1975; 26():129-30. PubMed ID: 1216085
[No Abstract] [Full Text] [Related]
10. Immune reactivity in patients with colorectal cancer: assessment of biologic risk by immunoparameters.
Wanebo HJ; Rao B; Attiyeh F; Pinsky C; Middleman P; Stearns M
Cancer; 1980 Mar; 45(5 Suppl):1254-63. PubMed ID: 7357518
[No Abstract] [Full Text] [Related]
11. Lymphoreticular cells within primary colorectal carcinoma: a surface marker study.
Werkmeister JA; Pihl E; Hughes ES; Cuthbertson AM; Rollo AJ
Clin Immunol Immunopathol; 1981 Mar; 18(3):415-24. PubMed ID: 7018768
[No Abstract] [Full Text] [Related]
12. Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells.
Nemoto T; Han T; Minowada J; Angkur V; Chamberlain A; Dao L
J Natl Cancer Inst; 1974 Sep; 53(3):641-5. PubMed ID: 4606319
[No Abstract] [Full Text] [Related]
13. Skin-reactive soluble antigen from intestinal cancer-cell-membranes and relationship to carcinoembryonic antigens.
Hollinshead A; Glew D; Bunnag B; Gold P; Herberman R
Lancet; 1970 Jun; 1(7658):1191-5. PubMed ID: 4192376
[No Abstract] [Full Text] [Related]
14. Prognostic significance of peripheral lymphocyte counts and carcinoembryonic antigens in colorectal carcinoma.
Kim US; Papatestas AE; Aufses AH
J Surg Oncol; 1976; 8(3):257-62. PubMed ID: 933547
[TBL] [Abstract][Full Text] [Related]
15. Immunologic study of carcinoma of the digestive tract. Effects of the tumor stage. I. Cellular immunity in the preoperative period.
Sanz ML; Subirá ML; Oehling A; Hernández JL; Zornoza G
Allergol Immunopathol (Madr); 1982; 10(1):33-42. PubMed ID: 7080994
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of colon cancer through measurement of carcinoembroyonic antigen levels, tests of cellular immune competence, and tumor specific immunity.
Holyoke ED; Goldrosen MH
Int Adv Surg Oncol; 1978; 1():85-111. PubMed ID: 399765
[No Abstract] [Full Text] [Related]
17. Correlation of immune responses with Dukes classification in colorectal carcinoma.
Jubert AV; Talbott TM; Mazier WP; MacKeigan JM; Campos MM; Benjamin HG; Muldoon JP; Ferguson JA; Maycroft TM; Bowman HE
Surgery; 1977 Oct; 82(4):452-9. PubMed ID: 302500
[No Abstract] [Full Text] [Related]
18. Some parameters of cell-mediated immunity in colon cancer patients.
Markova R; Argirova R; Boeva M
Neoplasma; 1980; 27(1):43-6. PubMed ID: 6966380
[TBL] [Abstract][Full Text] [Related]
19. Letter: rosette-forming-lymphocyte counts in cancer of the colon.
Seitanides B; Georgoulis B
Lancet; 1975 Feb; 1(7904):461. PubMed ID: 48655
[No Abstract] [Full Text] [Related]
20. Immunoreactivity by intrinsic lymphoid cells in colorectal carcinoma.
Werkmeister JA; Pihl E; Nind AP; Flannery GR; Nairn RC
Br J Cancer; 1979 Dec; 40(6):839-47. PubMed ID: 316708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
